Cannabinoid Receptor Agonists

"Cannabinoid Receptor Agonists" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Compounds that interact with and stimulate the activity of CANNABINOID RECEPTORS.

Descriptor ID	D063386
MeSH Number(s)	D27.505.519.625.085.500 D27.505.696.399.472.188.500
Concept/Terms	Cannabinoid Receptor Agonists Cannabinoid Receptor Agonists Agonists, Cannabinoid Receptor Receptor Agonists, Cannabinoid Cannabinoid Receptor Activators Activators, Cannabinoid Receptor Receptor Activators, Cannabinoid Cannabinoid Agonists Agonists, Cannabinoid

Below are MeSH descriptors whose meaning is more general than "Cannabinoid Receptor Agonists".

Chemicals and Drugs [D]
Chemical Actions and Uses [D27]
Pharmacologic Actions [D27.505]
Molecular Mechanisms of Pharmacological Action [D27.505.519]
Neurotransmitter Agents [D27.505.519.625]
Cannabinoid Receptor Modulators [D27.505.519.625.085]
Cannabinoid Receptor Agonists [D27.505.519.625.085.500]
Physiological Effects of Drugs [D27.505.696]
Hormones, Hormone Substitutes, and Hormone Antagonists [D27.505.696.399]
Hormones [D27.505.696.399.472]
Cannabinoid Receptor Modulators [D27.505.696.399.472.188]
Cannabinoid Receptor Agonists [D27.505.696.399.472.188.500]

Below are MeSH descriptors whose meaning is related to "Cannabinoid Receptor Agonists".

Below are MeSH descriptors whose meaning is more specific than "Cannabinoid Receptor Agonists".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Cannabinoid Receptor Agonists" by people in this website by year, and whether "Cannabinoid Receptor Agonists" was a major or minor topic of these publications.

Bar chart showing 7 publications over 6 distinct years, with a maximum of 2 publications in 2013

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2007	0	1	1
2008	1	0	1
2013	1	1	2
2014	1	0	1
2020	0	1	1
2022	0	1	1

Below are the most recent publications written about "Cannabinoid Receptor Agonists" by people in Profiles.

Kaczor EE, Greene K, Zacharia J, Tormoehlen L, Neavyn M, Carreiro S. The Potential Proconvulsant Effects of Cannabis: a Scoping Review. J Med Toxicol. 2022 07; 18(3):223-234.

View in: PubMed
Burstein S. Molecular Mechanisms for the Inflammation-Resolving Actions of Lenabasum. Mol Pharmacol. 2021 02; 99(2):125-132.

View in: PubMed
Fondevila MF, Fernandez U, Gonzalez-Rellan MJ, Da Silva Lima N, Buque X, Gonzalez-Rodriguez A, Alonso C, Iruarrizaga-Lejarreta M, Delgado TC, Varela-Rey M, Senra A, Garcia-Outeiral V, Novoa E, Iglesias C, Porteiro B, Beiroa D, Folgueira C, Tojo M, Torres JL, Hern?ndez-Cosido L, Blanco ?, Arab JP, Barrera F, Guallar D, Fidalgo M, L?pez M, Dieguez C, Marcos M, Martinez-Chantar ML, Arrese M, Garcia-Monzon C, Mato JM, Aspichueta P, Nogueiras R. The L-a-Lysophosphatidylinositol/G Protein-Coupled Receptor 55 System Induces the Development of Nonalcoholic Steatosis and Steatohepatitis. Hepatology. 2021 02; 73(2):606-624.

View in: PubMed
Amenta PS, Jallo JI, Tuma RF, Hooper DC, Elliott MB. Cannabinoid receptor type-2 stimulation, blockade, and deletion alter the vascular inflammatory responses to traumatic brain injury. J Neuroinflammation. 2014 Nov 22; 11:191.

View in: PubMed
Jourdan T, Godlewski G, Cinar R, Bertola A, Szanda G, Liu J, Tam J, Han T, Mukhopadhyay B, Skarulis MC, Ju C, Aouadi M, Czech MP, Kunos G. Activation of the Nlrp3 inflammasome in infiltrating macrophages by endocannabinoids mediates beta cell loss in type 2 diabetes. Nat Med. 2013 Sep; 19(9):1132-40.

View in: PubMed
Zajicek J, Ball S, Wright D, Vickery J, Nunn A, Miller D, Cano MG, McManus D, Mallik S, Hobart J. Effect of dronabinol on progression in progressive multiple sclerosis (CUPID): a randomised, placebo-controlled trial. Lancet Neurol. 2013 Sep; 12(9):857-865.

View in: PubMed
Bahremand A, Shafaroodi H, Ghasemi M, Nasrabady SE, Gholizadeh S, Dehpour AR. The cannabinoid anticonvulsant effect on pentylenetetrazole-induced seizure is potentiated by ultra-low dose naltrexone in mice. Epilepsy Res. 2008 Sep; 81(1):44-51.

View in: PubMed
Gholizadeh S, Shafaroodi H, Ghasemi M, Bahremand A, Sharifzadeh M, Dehpour AR. Ultra-low dose cannabinoid antagonist AM251 enhances cannabinoid anticonvulsant effects in the pentylenetetrazole-induced seizure in mice. Neuropharmacology. 2007 Nov; 53(6):763-70.

View in: PubMed

People

Explore

Similar Concepts

Top Journals